197 related articles for article (PubMed ID: 9590233)
1. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
[TBL] [Abstract][Full Text] [Related]
2. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
Cerundolo V; Benham A; Braud V; Mukherjee S; Gould K; Macino B; Neefjes J; Townsend A
Eur J Immunol; 1997 Jan; 27(1):336-41. PubMed ID: 9022037
[TBL] [Abstract][Full Text] [Related]
3. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?
Vinitsky A; Antón LC; Snyder HL; Orlowski M; Bennink JR; Yewdell JW
J Immunol; 1997 Jul; 159(2):554-64. PubMed ID: 9218569
[TBL] [Abstract][Full Text] [Related]
4. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.
Anton LC; Yewdell JW; Bennink JR
J Immunol; 1997 Mar; 158(6):2535-42. PubMed ID: 9058784
[TBL] [Abstract][Full Text] [Related]
5. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
[TBL] [Abstract][Full Text] [Related]
6. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
[TBL] [Abstract][Full Text] [Related]
7. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
López D; Del Val M
J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
[TBL] [Abstract][Full Text] [Related]
8. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
9. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
Serwold T; Shastri N
J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
[TBL] [Abstract][Full Text] [Related]
10. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.
Benham AM; Neefjes JJ
J Immunol; 1997 Dec; 159(12):5896-904. PubMed ID: 9550386
[TBL] [Abstract][Full Text] [Related]
11. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.
Yewdell J; Lapham C; Bacik I; Spies T; Bennink J
J Immunol; 1994 Feb; 152(3):1163-70. PubMed ID: 8301122
[TBL] [Abstract][Full Text] [Related]
12. A role for the proteasome regulator PA28alpha in antigen presentation.
Groettrup M; Soza A; Eggers M; Kuehn L; Dick TP; Schild H; Rammensee HG; Koszinowski UH; Kloetzel PM
Nature; 1996 May; 381(6578):166-8. PubMed ID: 8610016
[TBL] [Abstract][Full Text] [Related]
13. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
15. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.
Teoh CY; Davies KJ
Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471
[TBL] [Abstract][Full Text] [Related]
16. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
17. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL.
Deng Y; Yewdell JW; Eisenlohr LC; Bennink JR
J Immunol; 1997 Feb; 158(4):1507-15. PubMed ID: 9029084
[TBL] [Abstract][Full Text] [Related]
18. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation.
Grant EP; Michalek MT; Goldberg AL; Rock KL
J Immunol; 1995 Oct; 155(8):3750-8. PubMed ID: 7561079
[TBL] [Abstract][Full Text] [Related]
19. Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism.
Altuvia Y; Margalit H
J Mol Biol; 2000 Jan; 295(4):879-90. PubMed ID: 10656797
[TBL] [Abstract][Full Text] [Related]
20. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
Gileadi U; Moins-Teisserenc HT; Correa I; Booth BL; Dunbar PR; Sewell AK; Trowsdale J; Phillips RE; Cerundolo V
J Immunol; 1999 Dec; 163(11):6045-52. PubMed ID: 10570292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
